Treace Medical Concepts, Inc. - Common Stock (TMCI)
7.8500
-0.4700 (-5.65%)
NASDAQ · Last Trade: Apr 3rd, 10:01 AM EDT

Via Benzinga · March 3, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · February 28, 2025

Via Benzinga · February 7, 2025

Via Benzinga · January 21, 2025

Via Benzinga · December 18, 2024

Via Benzinga · January 17, 2025

Via Benzinga · December 31, 2024

Via Benzinga · November 6, 2024

Via Benzinga · November 6, 2024

Via Benzinga · July 16, 2024

Via Benzinga · November 6, 2024

Via Benzinga · November 6, 2024

Via Benzinga · August 16, 2024

Via Benzinga · May 21, 2024

Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.
Via Benzinga · May 8, 2024

Via Benzinga · May 8, 2024

Via Benzinga · May 8, 2024

DoubleVerify stock is falling on Wednesday as DV shareholders are disappointed by the company's weak guidance in its Q1 earnings report.
Via InvestorPlace · May 8, 2024

Treace Medical Concepts stock is falling on Wednesday as investors in TMCI shares react to a poor guidance in its latest earnings report.
Via InvestorPlace · May 8, 2024